ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,615Medicare Part D Prescriptions Filled, Including Refills

Rank: 110 out of 4623

$1.2M Total Retail Price of All Prescriptions

Rank: 88 out of 4623

737 Patients Receiving at Least One Drug in Part D
55%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 737 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

43% of this provider’s 737 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 9,995 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 1,817 506 S3 1 3
CARISOPRODOL 536 30 R 2 71
POTASSIUM CHLORIDE 516 383 3 14
FUROSEMIDE 431 314 4 8
LEVOTHYROXINE SODIUM 421 295 5 1
METFORMIN HCL 344 212 6 6
ZOLPIDEM TARTRATE 335 101 7 18
LISINOPRIL 326 212 8 4
OMEPRAZOLE 323 252 9 7
AMLODIPINE BESYLATE 305 242 10 5
SIMVASTATIN 295 202 11 2
ACETAMINOPHEN-CODEINE 293 92 S3 12 144
GABAPENTIN 240 138 13 16
TRAMADOL HCL 236 128 14 15
METOPROLOL TARTRATE 229 144 15 9
DONEPEZIL HCL 197 160 16 30
NAMENDA 179 161 17 36
PROMETHAZINE HCL 175 55 R 18 93
LISINOPRIL-HYDROCHLOROTHIAZIDE 171 79 19 19
CYMBALTA 166 100 20 48
LANTUS 161 95 21 44
DIVALPROEX SODIUM 156 120 22 90
HYDROCHLOROTHIAZIDE 148 84 23 10
SERTRALINE HCL 148 92 23 26
TAMSULOSIN HCL 147 125 25 29
CARVEDILOL 141 120 26 25
NEXIUM 131 57 27 17
CITALOPRAM HBR 130 88 28 23
AZITHROMYCIN 121 60 29 33
ABILIFY 120 55 30 161
NAPROXEN 115 72 31 63
TRAZODONE HCL 115 39 31 42
PANTOPRAZOLE SODIUM 107 58 33 35
PHENYTOIN SODIUM EXTENDED 101 44 34 119
LOSARTAN-HYDROCHLOROTHIAZIDE 101 75 34 46
NOVOLIN R 98 73 36 113
CLONIDINE HCL 97 57 37 40
ROPINIROLE HCL 95 81 38 108
RAMIPRIL 94 70 39 76
CYCLOBENZAPRINE HCL 93 24 R 40 53
RANITIDINE HCL 92 71 41 47
QUETIAPINE FUMARATE 91 61 42 74
ATORVASTATIN CALCIUM 89 64 43 12
LEVETIRACETAM 85 59 44 114
RISPERIDONE 85 53 44 72
FLUTICASONE PROPIONATE 83 56 46 32
MIRTAZAPINE 81 68 47 57
WARFARIN SODIUM 81 56 47 24
ISOSORBIDE MONONITRATE ER 79 74 49 60
LIDODERM 78 40 50 139
LYRICA 78 32 50 66
VENTOLIN HFA 77 14 52 134
DIVALPROEX SODIUM ER 74 14 53 148
SPIRIVA 74 51 53 79
IPRATROPIUM-ALBUTEROL 74 69 53 177
MELOXICAM 73 62 56 27
CLOPIDOGREL 73 51 56 31
TRIAMCINOLONE ACETONIDE 73 61 56 124
SINGULAIR 73 39 56 83
AMOXICILLIN 72 17 60 95
AMLODIPINE BESYLATE-BENAZEPRIL 70 61 61 55
NASONEX 69 27 62 171
SYMBICORT 69 47 62 151
SULFAMETHOXAZOLE-TRIMETHOPRIM 69 40 62 68
METOPROLOL SUCCINATE 68 60 65 13
PREDNISONE 66 58 66 50
SEROQUEL 66 54 66 149
OLANZAPINE 63 11 68 127
TRICOR 62 18 69 88
GLYBURIDE 62 43 R 69 59
CARBIDOPA-LEVODOPA 61 52 71 116
PREMARIN 60 19 R 72 140
ADVAIR DISKUS 60 48 72 62
ESCITALOPRAM OXALATE 58 35 74 75
JANUMET 58 44 74 136
POLYETHYLENE GLYCOL 3350 56 29 76 91
CELEBREX 55 30 77 89
CRESTOR 55 44 77 20
LEVOFLOXACIN 55 42 77 81
EXELON 55 46 77 107
BYSTOLIC 53 27 81 115
PLAVIX 51 35 82 45
SEROQUEL XR 51 13 82 235
ATENOLOL 50 34 84 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 6, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.